BridgeBio Pharma, Inc. (BBIO) has a market capitalization of $15.11B and trades at $77.93. The 52-week range is 28.325-84.94.
Key metrics include a trailing Price-to-Earnings (P/E) ratio of -20.6, Earnings Per Share (EPS) of $-3.79, annual revenue of $502.08M.
The stock has a beta of 1.09, operates in the Healthcare sector.
